CuraGenix Life Sciences

Menu
Facebook Twitter Youtube

Lorem ipsum dolor

Leave a Comment / Uncategorized / By

Nullam condimentum tristique ipsum iaculis dignissim. Proin non ligula non purus tincidunt ullamcorper vitae auctor risus. Pellentesque sagittis velit dui, eu scelerisque ante tempor a. Etiam molestie porta turpis sit amet vulputate. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sagittis eros lectus, et condimentum nibh tempus vel. Donec vitae lectus cursus, sollicitudin dolor at, sodales enim. Aliquam erat volutpat. Vivamus eget facilisis risus. Pellentesque vel ex ultrices, fringilla turpis ut, efficitur ipsum. Donec leo sapien, vulputate et blandit eget, ullamcorper vel leo. Aenean tempor luctus augue. Maecenas ac sollicitudin erat. In dignissim commodo turpis, quis blandit est varius vitae. Nulla malesuada pulvinar mi vel pellentesque. Donec eget felis lacinia, consequat nisl sit amet, luctus est.

Leave a Comment

Your email address will not be published. Required fields are marked *

Jason Yates

a seasoned leader and Managing Director of the CST Group of companies. With over two decades of experience in the healthcare and pharmaceutical industry, Jason has a proven track record of driving strategic initiatives, optimizing operations, and fostering strong relationships with suppliers and stakeholders. Jason is committed to innovation, growth, and ensuring the delivery of vital pharmaceuticals to healthcare providers across the world

Carl Falzon

is a dynamic and results-driven Commercial Director with a robust background in the pharmaceutical industry. With a career spanning over 20 years, Carl has displayed expertise in developing and executing commercial strategies that drive business growth and market expansion. His leadership has been instrumental in forging successful partnerships, negotiating key contracts, and implementing innovative sales and marketing initiatives to enhance market presence. Carl's sharp business acumen, coupled with a deep understanding of market dynamics, has consistently contributed to the success and profitability of the company's commercial operations, positioning the firm as a prominent player in the pharmaceutical sector.

Jonathan Dally

Jonathan is Our head of Business Development / Business Intelligence and Clinical Affairs has over 25 years of UK Pharma experience, covering various sectors including Clinical Trials, NHS tenders, Trade mark registration, Business Intelligence/ Business Development  and Clinical Affairs. He has a proven history of successfully managing several national / international clinical trials and more recently he has been hugely successful in attaining numerous NHS tender awards since 2018, including several National NHS Framework Agreement tender awards.  Furthermore, he is an author of academic and clinical trial-based publications,  As a leader and driver of business project programmes through effective project management, in accordance with the Company's processes, he has successfully collaborated with EU partners leading to the uptake of newly approved generic lines by the NHS (in both retail and hospital markets) and the regulatory submission of a new product line to the MHRA. In his current role, he provides science-based and clinical-based advice to the Senior Management Team/Board regarding in—licensing opportunities and acquisitions, as well as for collaborations with potential commercial partners wishing to sell licenced medicines, food supplements and medical devices in the UK.  He also performs due diligence reviews of potential product acquisitions / partnership opportunities and he works directly with contractors in order to ensure on-time and cost-effective delivery of high-quality output. He holds a BSc (Hons) degree in Pharmacology from Bath University and a Doctor of Philosophy (DPhil) degree from the University of Oxford.